Benjamin Mecsas‐Faxon, Konstantinos Papamichael, Adam S. Cheifetz. Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD—Is This the Time for Model Informed Precision Dosing?. // Alimentary Pharmacology and Therapeutics. – 2026. – DOI: 10.1111/apt.71087. – URL: https://onlinelibrary.wiley.com/doi/10.1111/apt.71087?af=R
Benjamin Mecsas‐Faxon, Konstantinos Papamichael, & Adam S. Cheifetz (2026). Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD—Is This the Time for Model Informed Precision Dosing?. Alimentary Pharmacology and Therapeutics. https://doi.org/10.1111/apt.71087
Benjamin Mecsas‐Faxon, et al. “Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD—Is This the Time for Model Informed Precision Dosing?.” Alimentary Pharmacology and Therapeutics, 2026. doi:10.1111/apt.71087.
@article{MecsasFaxon2026,
title = {Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD—Is This the Time for Model Informed Precision Dosing?},
author = {Mecsas‐Faxon, Benjamin and Papamichael, Konstantinos and Cheifetz, Adam S.},
journal = {Alimentary Pharmacology and Therapeutics},
year = {2026},
doi = {10.1111/apt.71087},
url = {https://onlinelibrary.wiley.com/doi/10.1111/apt.71087?af=R}
}